Guidelines for the clinical application of the Xihuang pill for the prevention and treatment of breast hyperplasia diseases

References

• Bai XL. 2010. Analysis of commonly used drugs and adverse effects in breast enlargement. Chinese Practical Med. 5(28):170–171.
   Google Scholar
• Chen J. 2007. Experimental study on the treatment of mammary hyperplasia in rats by Xihuang pill and its mechanism of action. [master’s thesis]. China (Jilin province): Yanbian University. (Chinese).
   Google Scholar
• Cheng ZH, Chen ZR, Zeng LH, Hc Y, Lu FH. 2010. Observation on the efficacy of Xihuang pill in treating 58 cases of breast hyperplasia. Chinese J Trad Chinese Med. 25:1919–1920. (Chinese).
   Google Scholar
• Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, Sharaf Aldeen B, Radisky DC, Frost MH, Visscher DW, et al. 2012. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 5(12):1375–1380. doi: 10.1158/1940-6207.CAPR-12-0175.
   PubMed Web of Science ®Google Scholar
• Cowin P, Wysolmerski J. 2010. Molecular mechanisms guiding embryonic mammary gland development. Cold Spring Harb Perspect Biol. 2(6):a003251–a003251. doi: 10.1101/cshperspect.a003251.
   PubMed Web of Science ®Google Scholar
• Ercan C, van Diest PJ, Vooijs M. 2011. Mammary development and breast cancer: the role of stem cells. Curr Mol Med. 11(4):270–285. doi: 10.2174/156652411795678007.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pei X, Liu Z, Xia Z, Zhang D, Song A, Liu D. 2013. Effectiveness of external Sanjierupi Gao on mastalgia caused by mammary gland hyperplasia: a placebo controlled trial. J Tradit Chin Med. 33(5):603–607. doi: 10.1016/s0254-6272(14)60028-5.
   PubMed Web of Science ®Google Scholar
• Gao YH, Tian Z, Wang XX, Yuan HE, Gao QZ. 2009. Observation on the therapeutic effect of Xihuang pill in the treatment of breast hyperplasia disease. In: Beijing Tongrentang Science and Technology Development Co., Chinese Journal of Traditional Chinese Medicine, Editors. [Proceedings of the Research on Clinical Application of Xihuang Pills]. Beijin(China): Chinese Association of Chinese Medicine. p. 114. (Chinese).
   Google Scholar
• Han T, Lan YM, Han P, Cheng ZQ. 2009. Clinical study on the treatment of breast hyperplasia by external application of Xihuang pill. Chinese Herbal Med. 32:1793–1794. (Chinese).
   Google Scholar
• Han T. 2020. Study on the mechanism of anti-mammary hyperplasia effect of Xihuang pill in regulating the hypothalamic-pituitary-ovarian axis. China (Gansu province): Gansu University of Chinese Medicine. (Chinese).
   Google Scholar
• Jin J. 2009. Clinical study on the treatment of breast hyperplasia by Xihuang pill together with Xiaoyao Pill. In: Beijing Tongrentang Science and Technology Development Co., Chinese Journal of Traditional Chinese Medicine, Editors. [Proceedings of the Research on Clinical Application of Xihuang Pills]. Beijing (China): Chinese Association of Chinese Medicine. p. 79. (Chinese).
   Google Scholar
• Li DH, Fan HF, Dong JF, Sun CX, Su YF, Liu J, Gu YT. 2021. Based on BATMAN-TCM to explore the molecular mechanism of Xihuang pill regulating immune function to treat breast precancerous lesions. Breast Cancer (Dove Med Press). 13:725–742. doi: 10.2147/BCTT.S339607.
   PubMed Web of Science ®Google Scholar
• Li X, Xin P, Wang C, Wang Z, Wang Q, Kuang H. 2017. Mechanisms of traditional Chinese medicine in the treatment of mammary gland hyperplasia. Am J Chin Med. 45(3):443–458. doi: 10.1142/S0192415X17500276.
   PubMed Web of Science ®Google Scholar
• Lian XL, Zhao M, Han Y, Wang QL, Han T. 2017. Effects of Xihuang pill on the morphology of mammary tissue and immune function in rats with mammary hyperplasia. PLA J Pharm. 33:496–498 + 513. (Chinese).
   Google Scholar
• Lian XL, Zhao M, Han Y, Wang QL, Han T. 2017. Effects of Xihuang pill on antioxidant capacity and expression of estrogen receptor and progesterone receptor in mammary tissue of rats with mammary hyperplasia. Chinese Med Pharmacol Clin. 33:9–12. (Chinese).
   Google Scholar
• Lian XL. 2019. Study on the mechanism of anti-mammary hyperplasia action of Xihuang pill. [master’s thesis]. China (Gansu province): Gansu University of Chinese Medicine. (Chinese).
   Google Scholar
• Lin LZ, Tang HM, Feng SY. 2023. Expert consensus on the clinical application of Xihuang pill in the prevention and treatment of hyperplastic breast diseases. Pharm Today. 1–8. (Chinese).
   Google Scholar
• Ma W, Jin QX, Wu YF, Jin F. 2016. Expert consensus on the diagnosis and treatment of breast hyperplasia. Chinese J Practical Surg. 36:759–762. (Chinese).
   Google Scholar
• Mao D, Feng L, Huang S, Zhang S, Peng W, Zhang S. 2019. Meta-analysis of Xihuang pill efficacy when combined with chemotherapy for treatment of breast cancer. Evid Based Complement Alternat Med. 2019:3502460. doi: 10.1155/2019/3502460.
   PubMed Web of Science ®Google Scholar
• Rungruang B, Kelley JL.3rd. 2011. Benign breast diseases: epidemiology, evaluation, and management. Clin Obstet Gynecol. 54(1):110–124. doi: 10.1097/GRF.0b013e318208010e.
   PubMed Web of Science ®Google Scholar
• Ryu K-J, Kim MS, Lee JY, Nam S, Jeong HG, Kim T, Park H. 2022. Risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment in premenopausal women with breast cancer. JAMA Netw Open. 5(11):e2243951. doi: 10.1001/jamanetworkopen.2022.43951.
   PubMed Web of Science ®Google Scholar
• Shi M, Ma Y, Xu P. 2022. Evaluation of the mechanism of Rujiling capsules in the treatment of hyperplasia of mammary glands based on network pharmacology and molecular docking. Indian J Pharmacol. 54(2):110–117.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao D, Di L, Cheng D, Zhou X, Yang X, Liu Y. 2011. The anti-hyperplasia of mammary gland effect of Thladiantha dubia root ethanol extract in rats reduced by estrogen and progestogen. J Ethnopharmacol. 134(1):136–140. doi: 10.1016/j.jep.2010.11.071.
   PubMed Web of Science ®Google Scholar
• Xie XY, Tang HM, Zheng ZH. 2021. Application of traditional chinese medicine in surgical diseases. Pharm Today. 31:405–408. (Chinese).
   Google Scholar
• Zeng LZ, Ding ZS. 2003. Clinical observation on 132 cases of breast hyperplasia treated by Xihuang pill with tamoxifen. Chinese Med Grassroots Level. (02):77. (Chinese).
   Google Scholar
• Zhang Q, Wen HB. 2006. Clinical observation on the treatment of breast hyperplasia by Xihuang pill together with Xiaoyao Pill. J Practical Med Technol. 14:2448–2449. (Chinese).
   Google Scholar
• Zhang BH, Gao SQ, Fu DX. 2009. Analysis of 17 cases of adverse reactions to Xihuang Pills. Chinese J Trad Chinese Med. 34:234–235. (Chinese).
   Google Scholar
• Zhang HB, Yan PH, Lu J, Sun L, Zhao LJ, Du X, Liu J. 2020. Clinical ­observation of electroacupuncture combined with scraping therapy for mammary hyperplasia. World J Acupunct Moxibustion. 30(2):146–150. doi: 10.1016/j.wjam.2020.02.011.
   Web of Science ®Google Scholar
• Zheng W, Han S, Jiang S, Pang L, Li X, Liu X, Cao M, Li P. 2016. Multiple effects of Xihuang pill aqueous extract on the Hs578T triple-negative breast cancer cell line. Biomed Rep. 5(5):559–566. doi: 10.3892/br.2016.769.
   PubMedGoogle Scholar
• Zheng ZH, Wu JY, Wei L, Li XY, Ji B, Wu HW. 2023. Surgical pharmacy: the knowledge system of surgical pharmacists. Eur J Hosp Pharm. 30(1):e2–e2. doi: 10.1136/ejhpharm-2021-002887.
   PubMedGoogle Scholar